Beyond pills and prescriptions: Exploring aging-related diseases with non-pharmacological strategies and molecular

Mahdi Esmaeilzadeh1,2, Nasrollah Moradikor3

  • 1Department of Cell and Molecular Biology, International Center for Neuroscience Research, Institute for Intelligent Research, Tbilisi, Georgia.

Aging and Disease
|March 12, 2025
PubMed

Insights

This study examines aging-related diseases and novel therapies, emphasizing lifestyle changes and emerging treatments like gene therapy. Addressing healthcare access barriers is crucial for promoting healthier aging globally.

Area of Science:

  • Gerontology and Molecular Biology
  • Focuses on the molecular underpinnings of aging and age-related diseases.

Background:

  • Aging is associated with numerous diseases.
  • Understanding molecular mechanisms is key to developing interventions.

Purpose of the Study:

  • To examine aging-related diseases and their molecular mechanisms.
  • To explore innovative therapeutic interventions, including non-pharmacological and emerging modalities.
  • To identify barriers to implementing these treatments and propose solutions.

Main Methods:

  • Comprehensive review of molecular mechanisms in aging-related diseases.
  • Analysis of non-pharmacological interventions (lifestyle, cognitive, social).
  • Evaluation of emerging therapies (gene therapy, precision medicine).

Main Results:

  • Identified intricate molecular pathways driving aging-related diseases.
  • Highlighted the potential of personalized lifestyle, cognitive, and social interventions.
  • Recognized gene therapy and precision medicine as promising future treatments.
  • Noted significant barriers including healthcare access and regulatory issues.

Conclusions:

  • Advancing understanding of aging biology is critical.
  • Innovative therapeutic approaches offer hope for healthier aging.
  • Overcoming healthcare access and regulatory hurdles is essential for equitable treatment implementation.
  • Collaborative efforts are needed to ensure global health equity and well-being in aging individuals.

Related Concept Videos

Aging01:26

Aging

Aging is a complex biological phenomenon influenced by various processes that affect cellular and systemic functions. Several prominent theories attempt to explain its mechanisms, highlighting cellular limitations, oxidative damage, and hormonal changes as central factors in aging.
Cellular Clock Theory
The cellular clock theory posits that the human lifespan is closely tied to the finite capacity of cells to divide, a phenomenon governed by telomeres, which are protective caps at the ends of...
21
Alzheimer's Disease: Overview01:26

Alzheimer's Disease: Overview

Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
313
Mitochondria01:37

Mitochondria

Mitochondria are eukaryotic cellular organelles that are known to produce energy through a process called oxidative phosphorylation. Besides their primary function, mitochondria are involved in various cellular processes, including cell growth, differentiation, signaling, metabolism, and senescence. Age-related changes cause a decline in mitochondrial quality and integrity due to increased mitochondrial mutations and oxidative damage. Thus, aging can severely impact mitochondrial functions,...
8.9K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
125
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.3K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.6K